Purpose: Role of intravitreal injection of dexamethasone implant (Ozurdex) for refractory macular thickening.
Methods: A case report of a 13-year-old boy with Rhodopsin-positive, CRB1-negative retinitis pigmentosa presenting with Coat's-like exudative vitreoretinopathy and treatment-resistant cystoid macular oedema.
Results: A reduction in the macular thickening following a single injection of Ozurdex.
Conclusion: We present our experience in successful treatment of refractory macular oedema with intravitreal injection of dexamethasone implant resulting in clinically significant resolution of macular thickening.